Literature DB >> 10725797

The scavenger receptor CD163: regulation, promoter structure and genomic organization.

M Ritter1, C Buechler, T Langmann, E Orso, J Klucken, G Schmitz.   

Abstract

CD163 is a recently identified member of the scavenger receptor cysteine-rich superfamily expressed on peripheral blood monocytes and most tissue macrophages. We demonstrate that in vitro culture of human blood monocytes with recombinant M-CSF induces CD163 transcription. In contrast, dendritic differentiation in the presence of GM-CSF and IL-4 suppresses CD163 mRNA and protein levels. Because an important function of CD163 in inflammation has been suggested, we investigated the influence of pro- and anti-inflammatory stimuli on CD163 expression and found a significant suppression by lipoposaccharide and IFN-gamma, whereas IL-10 or dexamethasone strongly induced the expression of CD163. The induction of CD163 mRNA by dexamethasone is suggested to be mediated by several glucocorticoid receptor binding sites located in the proximal promoter region. In addition, this sequence contains potential binding sites for the transcription factors Sp1, C/EBPalpha, Ets-2, PU.1 and AP-1, which have been shown to play an important role in myeloid-specific gene expression. We also identified an L1-transposable element 1.4 kb upstream of the transcription start site that might influence the promoter activity. The function of CD163 may also depend on the use of different isoforms. Several variants of CD163 mRNA have been described that encode proteins with altered cytoplasmic or extracellular domains and thus may differ in their functional properties. We analyzed the genomic organization of the CD163 gene and could demonstrate that these isoforms result from alternative splicing. Further characterization of the isoforms may help to understand the complete function of CD163. Copyright 2000 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10725797     DOI: 10.1159/000028105

Source DB:  PubMed          Journal:  Pathobiology        ISSN: 1015-2008            Impact factor:   4.342


  22 in total

1.  Evidence for cFMS signaling in HIV production by brain macrophages and microglia.

Authors:  Lindsey Gerngross; Tracy Fischer
Journal:  J Neurovirol       Date:  2014-07-25       Impact factor: 2.643

2.  Glucocorticoids enhance CD163 expression in placental Hofbauer cells.

Authors:  Zhonghua Tang; Tracy Niven-Fairchild; Serkalem Tadesse; Errol R Norwitz; Catalin S Buhimschi; Irina A Buhimschi; Seth Guller
Journal:  Endocrinology       Date:  2012-11-09       Impact factor: 4.736

Review 3.  Interleukin-10 suppression of myeloid cell activation--a continuing puzzle.

Authors:  Lynn M Williams; Giuseppe Ricchetti; Usha Sarma; Timothy Smallie; Brian M J Foxwell
Journal:  Immunology       Date:  2004-11       Impact factor: 7.397

4.  M2 macrophage infiltrates in the early stages of ANCA-associated pauci-immune necrotizing GN.

Authors:  Lei Zhao; Michael Z David; Elizabeth Hyjek; Anthony Chang; Shane M Meehan
Journal:  Clin J Am Soc Nephrol       Date:  2014-12-16       Impact factor: 8.237

5.  Up-regulation of CD163 expression in subpopulations of blood monocytes after kidney allograft transplantation.

Authors:  L Čurnová; K Mezerová; V Švachová; M Fialová; M Novotný; E Čečrdlová; O Viklický; I Stříž
Journal:  Physiol Res       Date:  2020-09-09       Impact factor: 1.881

6.  Evolution of the CD163 family and its relationship to the bovine gamma delta T cell co-receptor WC1.

Authors:  Carolyn T A Herzig; Ray W Waters; Cynthia L Baldwin; Janice C Telfer
Journal:  BMC Evol Biol       Date:  2010-06-15       Impact factor: 3.260

7.  CD163/CD16 coexpression by circulating monocytes/macrophages in HIV: potential biomarkers for HIV infection and AIDS progression.

Authors:  Tracy Fischer-Smith; Ellen M Tedaldi; Jay Rappaport
Journal:  AIDS Res Hum Retroviruses       Date:  2008-03       Impact factor: 2.205

8.  CXCL4 downregulates the atheroprotective hemoglobin receptor CD163 in human macrophages.

Authors:  Christian A Gleissner; Iftach Shaked; Christian Erbel; Dittmar Böckler; Hugo A Katus; Klaus Ley
Journal:  Circ Res       Date:  2009-11-12       Impact factor: 17.367

9.  Soluble CD163 and soluble mannose receptor predict survival and decompensation in patients with liver cirrhosis, and correlate with gut permeability and bacterial translocation.

Authors:  F Rainer; A Horvath; T D Sandahl; B Leber; B Schmerboeck; A Blesl; A Groselj-Strele; R E Stauber; P Fickert; P Stiegler; H J Møller; H Grønbaek; V Stadlbauer
Journal:  Aliment Pharmacol Ther       Date:  2017-12-21       Impact factor: 8.171

10.  The clinical significance of the CD163+ and CD68+ macrophages in patients with hepatocellular carcinoma.

Authors:  Ling-Qun Kong; Xiao-Dong Zhu; Hua-Xiang Xu; Ju-Bo Zhang; Lu Lu; Wen-Quan Wang; Qiang-Bo Zhang; Wei-Zhong Wu; Lu Wang; Jia Fan; Zhao-You Tang; Hui-Chuan Sun
Journal:  PLoS One       Date:  2013-03-29       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.